5.1 Molecular Biology/Cytogenetic Facilities 14-1C-103l, Cytogenetic and molecular biology investigations on sarcoma cases will be provided by the following hospitals: Royal Marsden Hospital: Prof. Cyril Fisher Birmingham Hospital: Chaz Mangham 5.2 Designated GIST Histopathologists 14-1C-108l The designated consultant histopathologists who and only who will be responsible for the final reporting and reviewing of the histological diagnosis of GIST is Dr Bracey, Plymouth Hospitals NHS Trust, who is a Lead Pathologist for the Plymouth Hospitals NHS Trust Upper GI SMDT and participate s in a EQA scheme. 6. Coordination of Care/Patient Pathways Primary Care Referral Guidelines Primary Care practitioners will refer all patients defined by the suspicious of cancer” “urgent, guidelines for sarcomas to the contact point at the local designated Diagnostic Clinic. Referral Guidelines for Patients Moving Between 6.2 Referring clinicians should ensure that all relevant information is provided to facilitate the continuity of care and avoid unnecessary delays. The Peninsula Tertiary Referral Form (TRF01) should be used when referring patients to another Acute Trust for specialist investigation or treatment and sent within one working day of the referral being made see PCN information policy to support data transfer, this form accompanies the clinical referral. ? Patients with synchronous sarcomas and cancers at other sites Such patients will be discussed in the Sarcoma MDT. Lead responsibility will be shared with the other MDT, until it becomes clear which MDT would be best to lead in each individual case. Network guidelines will be reviewed at least every three years or on the publication of new guidance. It is the responsibility of the of the Group to ensure that all Network guidelines are up to date and reflect current practice. 6.3 Clinical Guidelines for Soft Tissue Sarcoma Limb & Trunk 14-1C-109l – The Sarcoma Group has agreed clinical guidelines for the management of soft tissue sarcoma. The Group has adopted the Peninsula Radiotherapy Guidelines and Protocols for soft tissue sarcoma.
5.1 Molecular Biology/Cytogenetic Facilities 14-1C-103l, Cytogenetic and molecular biology investigations on sarcoma cases will be provided by the following hospitals: Royal Marsden Hospital: Prof. Cyril Fisher Birmingham Hospital: Chaz Mangham 5.2 Designated GIST Histopathologists 14-1C-108l The designated consultant histopathologists who and only who will be responsible for the final reporting and reviewing of the histological diagnosis of GIST is Dr Bracey, Plymouth Hospitals NHS Trust, who is a Lead Pathologist for the Plymouth Hospitals NHS Trust Upper GI SMDT and participate s in a EQA scheme. 6. Coordination of Care/Patient Pathways Primary Care Referral Guidelines Primary Care practitioners will refer all patients defined by the “urgent, suspicious of cancer” guidelines for sarcomas to the contact point at the local designated Diagnostic Clinic. 6.2 Referral Guidelines for Patients Moving Between Referring clinicians should ensure that all relevant information is provided to facilitate the continuity of care and avoid unnecessary delays. The Peninsula Tertiary Referral Form (TRF01) should be used when referring patients to another Acute Trust for specialist investigation or treatment and sent within one working day of the referral being made see PCN information policy to support data transfer, this form accompanies the clinical referral. ? Patients with synchronous sarcomas and cancers at other sites Such patients will be discussed in the Sarcoma MDT. Lead responsibility will be shared with the other MDT, until it becomes clear which MDT would be best to lead in each individual case. Network guidelines will be reviewed at least every three years or on the publication of new guidance. It is the responsibility of the of the Group to ensure that all Network guidelines are up to date and reflect current practice. 6.3 Clinical Guidelines for Soft Tissue Sarcoma – Limb & Trunk 14-1C-109l The Sarcoma Group has agreed clinical guidelines for the management of soft tissue sarcoma. The Group has adopted the Peninsula Radiotherapy Guidelines and Protocols for soft tissue sarcoma.
PCN_Sarcoma-Constitution_2015-draft-v0.1-2.4.15.docx